Delivery Order SPE2DB20D3505-SPE2DB25FU8B2
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $10,797.45. The contract type is Firm Fixed Price, and the ultimate completion date is May 23, 2025. This contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $9,944.75. It is a firm fixed-price delivery order contract with a performance period through March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,201.72, is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, with a period of performance through March 1, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, with a ceiling value of $11,603.06 and a period of performance through October 2024. The contract is not designated as a set-aside and is a firm fixed-price arrangement. It is associated with a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,579.83 firm fixed-price contract is for the supply of GILENYA 0.5 MG CAPSULE, a pharmaceutical product, with an ultimate completion date of October 25, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,232.00 contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The contract has a firm-fixed price pricing type and an ultimate completion date of July 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a $27,861.73 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with a period of performance through August 29, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military...
This is a federal delivery order award to AmerisourceBergen Drug Corp for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $48,828.20. The award is under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty pharmaceutical product, with a ceiling value of $6,158.65 and a period of performance through March 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program....
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,556,764,359 units of the medication GILENYA 0.5 MG CAPSULE. The $18,358.08 firm fixed-price delivery order has an ultimate completion date of April 4, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the...